TransCode Therapeutics, Inc. (RNAZ)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Nov 05, 16:00
TransCode Therapeutics Market Cap : 1.528M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.528M |
| November 04, 2026 | 1.619M |
| November 03, 2026 | 1.588M |
| November 02, 2026 | 1.649M |
| October 30, 2026 | 1.649M |
| October 29, 2026 | 1.750M |
| October 28, 2026 | 1.760M |
| October 27, 2026 | 1.689M |
| October 26, 2026 | 1.725M |
| October 23, 2026 | 1.790M |
| October 22, 2026 | 1.735M |
| October 21, 2026 | 1.679M |
| October 20, 2026 | 1.700M |
| October 19, 2026 | 1.720M |
| October 16, 2026 | 1.720M |
| October 15, 2026 | 1.821M |
| October 14, 2026 | 1.750M |
| October 13, 2026 | 1.700M |
| October 12, 2026 | 1.649M |
| October 09, 2026 | 1.882M |
| October 08, 2026 | 1.730M |
| October 07, 2026 | 1.780M |
| October 06, 2026 | 1.801M |
| October 05, 2026 | 1.780M |
| October 02, 2026 | 1.588M |
| Date | Value |
|---|---|
| October 01, 2026 | 1.563M |
| September 30, 2026 | 1.700M |
| September 29, 2026 | 1.649M |
| September 28, 2026 | 1.730M |
| September 25, 2026 | 1.710M |
| September 24, 2026 | 1.669M |
| September 23, 2026 | 1.700M |
| September 22, 2026 | 1.790M |
| September 21, 2026 | 1.780M |
| September 18, 2026 | 1.669M |
| September 17, 2026 | 1.74M |
| September 16, 2026 | 1.700M |
| September 15, 2026 | 1.619M |
| September 14, 2026 | 1.669M |
| September 11, 2026 | 1.710M |
| September 10, 2026 | 1.710M |
| September 09, 2026 | 1.801M |
| September 08, 2026 | 1.912M |
| September 04, 2026 | 2.084M |
| September 03, 2026 | 2.18M |
| September 02, 2026 | 2.033M |
| September 01, 2026 | 2.084M |
| August 31, 2026 | 2.124M |
| August 28, 2026 | 2.205M |
| August 27, 2026 | 2.306M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.125B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.898B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| Price | 1.51 |
| Earnings Yield | -3.36K% |